Blood Glucose, Cognition and Wellbeing @ Work

March 23, 2020 updated by: Iris de Hoogh, TNO

Blood Glucose Monitoring, Cognition, and Wellbeing in Relation to Food Intake @ Work - a Pilot Study

This randomized controlled pilot study has as a main aim to investigate the relationship between glucose and cognition and wellbeing, as well as food intake in an at-work setting. Additionally, the continuous glucose data collected in the study will be used to investigate the inter- and intraindividual variability in glucose response to foods/meal in a real-life setting.

Finally, the study aims to determine if self-monitoring and feedback about food intake and health stimulate individuals to make healthier choices.

This study will have two groups, the feedback group and the control group. The study will consist of two self-monitoring periods of two weeks. In between these two self-monitoring periods, the participants in the feedback group will be given feedback on their measurement data. The control group will not get any feedback.

Study Overview

Detailed Description

Many people in the Western world have an unhealthy lifestyle, including an unhealthy dietary pattern. Numerous approaches have been taken to stimulate people to maintain a more healthy diet, but results are highly variable across studies and subjects. One explanation for this is that in many approaches the individuals' specific needs and the context they live and work in are not sufficiently taken into account. For an approach to be more effective, personal characteristics need to be taken into account. In other words, the approach needs to be tailored or personalised. When focussing on personalized nutrition and health in the work environment, the aspects of health that are included in the study should also be relevant for the work environment. Three main parameters of interest are selected: (postprandial) blood glucose levels, cognition and (subjective) wellbeing.

Objective:

The primary objective of this pilot study is to investigate the relationship between glucose and cognition and wellbeing, as well as food intake in an at-work setting.

Secondary objectives are :1) Does self-monitoring and feedback about food intake and health stimulate individuals to make healthier choices? 2) What are the user experiences of employees to perform self-monitoring of and receive feedback on, glucose, wellbeing and cognition in the workplace?

Study design:

This study will be designed as a randomized controlled trial with two groups, the feedback group and the control group. The study will consist of two self-monitoring periods of two weeks. In between these two self-monitoring periods, the participants in the feedback group will be given feedback on their measurement data. The control group will not get any feedback.

Study population:

Forty participants, both men and women, will be recruited from the staff at the head-quarters of Jumbo supermarkets in Veghel. Inclusion criteria are presence at head-quarters for at least 4 days per week and frequent visitors of the company lunch restaurant. Exclusion criteria are shift work, diabetic patients, neurological or psychiatric complaints and specific food-related allergies.

Intervention:

The intervention consists of standardized meals and personalized feedback. During the first two-week measurement period study participants will be asked to consume standardized lunches at work days in the company restaurant. In between the two measurement periods, the feedback group will receive personalized feedback on their self-measured data (interstitial glucose, cognition, wellbeing, and food intake). At the end of the second measurement period both the feedback group and the control group will receive a personalized feedback form, including a debriefing about the study.

Main study parameters/endpoints:

Primary endpoints are self-monitored daily food intake, glucose levels, cognitive performance, and wellbeing.

Study Type

Interventional

Enrollment (Actual)

45

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Noord-Brabant
      • Veghel, Noord-Brabant, Netherlands, 5462 CE
        • Jumbo Supermarkten BV.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 67 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Must be present at Jumbo head-quarters during lunch at least four days/week and have access to their computer for one hour after lunch during the two 2-week self-monitoring periods
  • Must be frequent visitors of the company lunch restaurant (Jumbo food café), with a minimum of three times per week
  • Having giving written informed consent
  • Willing to comply with all study procedures

Exclusion Criteria:

  • Shift workers
  • Diabetes type 2 patients
  • Under treatment for neurological or psychiatric complaints, including eating disorders
  • Specific dietary preferences, including vegan, raw food, paleo. Vegetarian, pescetarians and flexitarians can participate in the study
  • Allergies or intolerances, including coeliac disease, gluten intolerance, lactose intolerance, milk protein allergy
  • Skin allergy or eczema

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Personalized feedback group
In between the two measurement periods, the personalized feedback group will receive an explanation and personalized feedback on their self-measured data (interstitial glucose, cognition, wellbeing and food intake).

The personalized feedback report will contain a general explanation about glucose, cognition and wellbeing, healthy cut-offs and/or benchmark values, and why these measures are relevant for personal health and wellbeing. Also, a general explanation will be given about how glucose levels can be influenced.

Also, the personalized feedback will contain the individual glucose response profiles, as well as graphs showing the wellbeing scores over time. The registered food intake will be mapped and linked to the glucose and wellbeing profiles. The results of the wellbeing questionnaire will also be shown and will be linked to the individual profiles and food intake.

Other Names:
  • personalized feedback report
This is not an intervention, but a measurement device used during the study. Added here as intervention to avoid errors in the system.
Other Names:
  • Abbott FreeStyle Libre Pro
Placebo Comparator: General feedback group
The generic feedback group will receive a generic explanation about glucose, cognition wellbeing and food intake and their relationship. The generic feedback will not include personal results.
This is not an intervention, but a measurement device used during the study. Added here as intervention to avoid errors in the system.
Other Names:
  • Abbott FreeStyle Libre Pro
The generic feedback will contain a generic explanation about glucose, cognition wellbeing and food intake and their relationship. The generic feedback will not include personal results.
Other Names:
  • Generic feedback report

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Daily glucose levels
Time Frame: Continous (sampled every 15 minutes for a duration of 14 days)
measured using a continuous glucose monitoring device
Continous (sampled every 15 minutes for a duration of 14 days)
Daily food intake
Time Frame: daily registration of food intake during working hours for a duration of 14 days (during both the two week measurement periods)..
measured using a food intake application
daily registration of food intake during working hours for a duration of 14 days (during both the two week measurement periods)..
Cognition tests
Time Frame: twice per day (before and after lunch) at working days for a duration of 14 days, during both the two week measurement periods
via Smartphone application. Tests include direct recall, free recall & delayed recall.
twice per day (before and after lunch) at working days for a duration of 14 days, during both the two week measurement periods
Wellbeing
Time Frame: This questionnaire will be administered five times per day; two times in the morning, once five minutes before lunch (before with cognition test), once one hour after lunch (before cognition test) and once in the afternoon for two times 14 days.
via Smartphone application. Includes VAS scales for including five questions for 'feeling energetic - tired, 'feeling focused - distracted', 'feeling positive - negative' , 'feeling motivated - unmotivated' , 'feeling relaxed - stressed'
This questionnaire will be administered five times per day; two times in the morning, once five minutes before lunch (before with cognition test), once one hour after lunch (before cognition test) and once in the afternoon for two times 14 days.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Intention to eat healthy
Time Frame: baseline and after eight weeks (end of study)
measured with three items on seven-point scales from totally disagree (1) to totally agree (7). The items are 'I'm planning on eating healthy', 'I would consider to eat healthy' and 'I'm absolutely going to eat healthy'.
baseline and after eight weeks (end of study)
Quantitative user experiences
Time Frame: baseline and after eight weeks (end of study)
Self-efficacy towards maintaining a healthy diet and type of motivation to eat healthy
baseline and after eight weeks (end of study)
Qualitative user experiences
Time Frame: four short surveys (baseline, day 1, after two weeks, after eight weeks) and in focus groups after eight weeks
the survey includes self-constructed scales that measure user experience with the research in general, self-monitoring devices and personal feedback. Focus groups are needed to understand the reasoning behind the answers that employees give in the surveys and to validate initial analysis of the survey.
four short surveys (baseline, day 1, after two weeks, after eight weeks) and in focus groups after eight weeks

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Focus on future consequences
Time Frame: baseline
validated questionnaire from Joireman et al (2012). Output will be used as input for formulating the personalized feedback
baseline
Subjective health
Time Frame: Baseline and after eight weeks (end of study)
• Subjective health is measured with two items that are rated on seven-point scales from 'very unhealthy' (1) to 'very healthy' (7).
Baseline and after eight weeks (end of study)
Eating habits (at the workplace)
Time Frame: Baseline and after eight weeks (end of study)
mapped via a questionnaire, concerning how often one eats breakfast and snacks, how often one eats in the company restaurant at work, how often one brings their own lunch or buys their lunch, how often one goes on lunch walks etc.
Baseline and after eight weeks (end of study)
Physical activity
Time Frame: Baseline and after eight weeks (end of study)
the Dutch Norm for Healthy Physical Activity.
Baseline and after eight weeks (end of study)
BMI
Time Frame: Baseline and after eight weeks (end of study)
calculated based on self-reported height and weight
Baseline and after eight weeks (end of study)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

TNO

Investigators

  • Principal Investigator: Iris M de Hoogh, Msc, TNO (Netherlands Organization for Applied Scientific Research)

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 2, 2017

Primary Completion (Actual)

November 17, 2017

Study Completion (Actual)

December 22, 2017

Study Registration Dates

First Submitted

September 12, 2017

First Submitted That Met QC Criteria

September 24, 2017

First Posted (Actual)

September 28, 2017

Study Record Updates

Last Update Posted (Actual)

March 24, 2020

Last Update Submitted That Met QC Criteria

March 23, 2020

Last Verified

March 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on Personalized feedback

3
Subscribe